Report Categories
View AllRecent Articles
View All
Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval
Why Global GWRS cost structure is getting attention GWRS Q4 2025 Earnings Global Misses Estimates Posts Loss
ARTV Artiva Bio drops 867 after Q4 2025 EPS posts narrow miss versus analyst estimates
VNCE Vince Holding posts 782 percent Q1 2026 EPS surprise far exceeding analyst consensus projections
How Haymaker HYAC earnings track against industry trends Q4 2025 Profit Surprises
Southern Co SO Q1 2026 Earnings Outlook Wall Street Consensus Estimates for Core Operational and Financial Metrics
What iSpecimen ISPC is doing that smart investors recognize In Focus 20260503
RILYT BRC Group shares rise 231 percent following Q1 2024 earnings despite reporting a negative 171 dollar per share profit
What Xerox XRX is doing that smarter investors notice Smart Money Exits 20260508
Why trivago TRVG could be the anchor your portfolio needs 1076 20260506